Progyny Inc 's ability to collect accounts receivable sequentially worsen to 5.09, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Progyny Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 72 days, from 71 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 24 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 253 to 254.

What is Receivable Turnover Ratio?
What is Progyny Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PGNY Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	8.1 %	-12.05 %	-6.39 %	-10.05 %	-7.47 %
Y / Y Revenue Change	5.58 %	1.32 %	6.83 %	9.29 %	9.46 %
Receivable Turnover Ratio (TTM)	5.09	5.13	4.93	4.79	4.57
PGNY's Total Ranking	# 254	# 253	# 252	# 238	# 210
Accounts Receivable average collection period days	72	71	74	76	80
Seq. Receivable Change	11.48 %	19.67 %	-12.76 %	-7.12 %	-9.3 %
Seq. Revenue Change	6.84 %	2.56 %	2.25 %	-5.76 %	2.53 %

Receivable Turnover Company Ranking
Within:	No.
Healthcare Facilities Industry	# 5
Healthcare Sector	# 25
Overall Market	# 254

Receivable Turnover Ratio Statistics
High	Average	Low
1.8	1.52	0.22
(Jun 30 2025)		(Sep 30 2019)

PGNY Company Profile • Back to PGNY Efficiency Comparisons • Compare PGNY Receivables Turnover Ratio to its Competitors

Financial Statements
Progyny Inc 's Accounts Receivable	$ 294 Millions	Visit PGNY's Balance sheet
Progyny Inc 's Sales TTM	$ 1,311 Millions	Visit PGNY's Income Statement
Sources of PGNY's Revenues		Visit PGNY's Sales by Geography

Other Accounts Receivable Turnover Ratios
Healthcare Facilities Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PGNY's Receivable Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PGNY's Growth Rates	PGNY's Roa	PGNY's Inventory Turnover Ratio	PGNY's Dividend Comparisons
PGNY's Profitability Ratios	PGNY's Roi	PGNY's Asset Turnover Ratio	PGNY's Dividend Growth
PGNY's Valuation Ratios	PGNY's Roe	PGNY's Financial Strength Ratios	PGNY's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Alpha Pro Tech Ltd	12.25	$ 62.204 Millions	$ 5.077 Millions
Vivos Therapeutics Inc	12.21	$ 21.135 Millions	$ 1.731 Millions
Milestone Scientific Inc	11.82	$ 8.855 Millions	$ 0.749 Millions
Teladoc Health Inc	11.74	$ 2,489.480 Millions	$ 212.023 Millions
Marpai Inc	11.71	$ 16.635 Millions	$ 1.420 Millions
Catheter Precision Inc	11.62	$ 1.915 Millions	$ 0.165 Millions
Icu Medical Inc	11.42	$ 2,159.998 Millions	$ 189.166 Millions
National Healthcare Corp	11.40	$ 1,559.020 Millions	$ 136.723 Millions
Nrc Health	11.35	$ 139.996 Millions	$ 12.337 Millions
Picard Medical Inc	11.34	$ 5.983 Millions	$ 0.528 Millions
Innoviva Inc	11.22	$ 420.630 Millions	$ 37.491 Millions
Veracyte Inc	11.07	$ 544.735 Millions	$ 49.194 Millions
International Stem Cell Corporation	10.91	$ 9.514 Millions	$ 0.872 Millions
Caredx Inc	10.81	$ 458.089 Millions	$ 42.359 Millions
Premier Air Charter Holdings Inc	10.66	$ 31.562 Millions	$ 2.961 Millions
C4 Therapeutics Inc	10.65	$ 35.039 Millions	$ 3.290 Millions
Kymera Therapeutics Inc	10.50	$ 105.000 Millions	$ 10.000 Millions
Lifeloc Technologies Inc	10.48	$ 9.269 Millions	$ 0.884 Millions
Irhythm Holdings Inc	10.42	$ 825.702 Millions	$ 79.250 Millions
Immucell Corporation	10.29	$ 29.777 Millions	$ 2.893 Millions
Addus Homecare Corp	10.23	$ 1,475.610 Millions	$ 144.195 Millions
Dariohealth Corp	10.23	$ 21.196 Millions	$ 2.072 Millions
Biodesix Inc	10.21	$ 102.939 Millions	$ 10.081 Millions
Viemed Healthcare Inc	10.18	$ 301.606 Millions	$ 29.637 Millions
Radnet Inc	10.11	$ 2,268.932 Millions	$ 224.447 Millions
Kestra Medical Technologies Ltd	10.00	$ 105.939 Millions	$ 10.590 Millions
United Therapeutics Corporation	9.93	$ 3,154.500 Millions	$ 317.550 Millions
Utah Medical Products Inc	9.88	$ 35.679 Millions	$ 3.612 Millions
Lensar Inc	9.75	$ 60.264 Millions	$ 6.184 Millions
Biolife Solutions Inc	9.67	$ 102.718 Millions	$ 10.626 Millions

Date modified: 2026-08-14T20:54:24+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.